Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v7-EN
Language English English
Date Updated 2019-11-08 2019-11-08
Drug Identification Number 02247008 02247008
Brand name TEVA-PRAVASTATIN TEVA-PRAVASTATIN
Common or Proper name TEVA-PRAVASTATIN TEVA-PRAVASTATIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PRAVASTATIN SODIUM PRAVASTATIN SODIUM
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-22 2019-08-22
Estimated end date 2019-12-31 2019-12-31
Actual end date 2019-11-07 2019-11-07
Shortage status Resolved Resolved
Company comments
Health Canada comments